| FLORIDA                                                                       | 11-3331350                                          |
|-------------------------------------------------------------------------------|-----------------------------------------------------|
| (State                or other jurisdiction of incorporation or organization) | (I.R.S.                Employer Identification No.) |

----

| UniverCell                Holdings, Inc.(A                Development Stage Company) |   |
|--------------------------------------------------------------------------------------|--------|
| Consolidated                Balance Sheets                                           |   |
| (Unaudited)                                                                          |
| ASSETS                                                                               |   |
|                                                                                 |   |   |   |   |   |
|                                                                                 |   | June                30, |   | December                31, |   |
|                                                                                 |   | 2006 |   | 2005 |   |
|                                                                                 |   | (Unaudited) |   |   |   |
| Current                Assets                                                        |   |   |   |   |   |
| Cash                                                                                 |   | $ | 100 |   | $ | 2,530 |   |
|                                                                                 |   |   |   |   |   |   |   |
| Total                Current Assets                                                  |   | $ | 100 |   | $ | 2,530 |   |
|                                                                                 |   |   |   |   |   |   |   |

| LIABILITIES                AND STOCKHOLDERS' EQUITY                                                                            |   |
|--------------------------------------------------------------------------------------------------------------------------------|--------|
|                                                                                                                           |   |   |   |   |   |
|                                                                                                                           |   | June                30, |   | December                31, |   |
|                                                                                                                           |   | 2006 |   | 2005 |   |
|                                                                                                                           |   | (Unaudited) |   |   |   |
| Current                Liabilities                                                                                             |   |   |   |   |   |
| Accounts                Payable                                                                                                |   | $ | 6,926 |   | $ | 6,926 |   |
| Accrued                Expenses                                                                                                |   |   | 75,808 |   |   | 202,620 |   |
| Notes                Payable - Related Party                                                                                   |   |   | 261,192 |   |   | - |   |
|                                                                                                                           |   |   |   |   |   |   |   |
| Total                Current Liabilities                                                                                       |   |   | 343,926 |   |   | 209,546 |   |
|                                                                                                                           |   |   |   |   |   |   |   |
| Stockholders'                Equity                                                                                            |   |   |   |   |   |   |   |
| Common                Stock, Authorized 200,000,000 Shares, $.0001Par Value, Issued and                Outstanding 199,250,000 |   |   |   |   |   |   |   |
|                                                                                                                           |   |   | 19,925 |   |   | 19,925 |   |
| Additional                Paid in Capital                                                                                      |   |   | 1,305,380 |   |   | 1,305,380 |   |
| Retained                Earnings (Deficit)                                                                                     |   |   | (1,669,131 | ) |   | (1,532,322 | ) |
|                                                                                                                           |   |   |   |   |   |   |   |
| Total                Stockholders' Equity                                                                                      |   |   | (343,826 | ) |   | (207,016 | ) |
|                                                                                                                           |   |   |   |   |   |   |   |
| 1                Total Liabilities and Stockholders' Equity                                                                    |   | $ | 100 |   | $ | 2,530 |   |

----

| UniverCell                Holdings, Inc.(A                Development Stage Company)             |   |
|--------------------------------------------------------------------------------------------------|--------|
| Consolidated                Statements of Operations                                             |   |
| (Unaudited)                                                                                      |   |
|                                                                                             |   |
|                                                                                             |   | For                the Three Months Ended |   | For                the Six Months Ended |   |
|                                                                                             |   | June                30, |   | June                30, |   |
|                                                                                             |   | 2006 |   | 2005 |   | 2006 |   | 2005 |   |
|                                                                                             |   |   |   |   |   |   |   |   |   |
| Revenues                                                                                         |   | $ | - |   | $ | - |   | $ | - |   | $ | - |   |
|                                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Cost                of Sales                                                                     |   |   | - |   |   | - |   |   | - |   |   | - |   |
|                                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Gross                Profit (Loss)                                                               |   |   | - |   |   | - |   |   | - |   |   | - |   |
|                                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Operating                Expenses                                                                |   |   |   |   |   |   |   |   |   |   |   |   |   |
| General                & Administrative                                                      |   |   | 74,232 |   |   | 73,986 |   |   | 136,809 |   |   | 157,825 |   |
|                                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Total                Operating Expenses                                                          |   |   | 74,232 |   |   | 73,986 |   |   | 136,809 |   |   | 157,825 |   |
|                                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Net                Operating Income (Loss) from continuingOperations                             |   |   | (74,232 | ) |   | (73,986 | ) |   | (136,809 | ) |   | (157,825 | ) |
|                                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Other                Income (Expense)                                                            |   |   | - |   |   | - |   |   | - |   |   | - |   |
| Interest                Income                                                                   |   |   | - |   |   | - |   |   | - |   |   | 30 |   |
| Interest                Expense                                                                  |   |   | - |   |   | - |   |   | - |   |   | - |   |
| Loss                before provision for income taxes and discontinued                operations |   |   | (74,232 | ) |   | (73,986 | ) |   | (136,809 | ) |   | (157,795 | ) |
| Provision                for Income Taxes                                                        |   |   | - |   |   | - |   |   | - |   |   | - |   |
|                                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Loss                from continuing operations before discontinued operations                    |   |   | (74,232 | ) |   | (73,986 | ) |   | (136,809 | ) |   | (157,795 | ) |
| Gain                (Loss) on disposal of Discontinued operations (net of                taxes)  |   |   | - |   |   | - |   |   | - |   |   | 376.705 |   |
|                                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Net                Income (Loss)                                                                 |   |   | (74,232 | ) |   | (73,986 | ) |   | (136,809 | ) |   | 218,910 |   |
|                                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Net                Income (Loss) Per share for continuing operations                             |   | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) |
|                                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Net                Income (Loss) Per Share for discontinued operations                           |   | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) |
|                                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Weighted                Average Shares Outstanding                                               |   |   | 199,250,000 |   |   | 159,521,947 |   |   | 199,250,000 |   |   | 199,250,000 |   |

----

| UniverCell                Holdings, Inc.(A                Development Stage Company)                      |   |
|-----------------------------------------------------------------------------------------------------------|--------|
| Consolidated                Statements of Cash Flows                                                      |   |
|  (Unaudited)                                                                                         |   |
|                                                                                                      |   |   |   | For                the six months ended |   |
|                                                                                                      |   |   |   | June                30, |   |
|                                                                                                      |   |   |   | 2006 |   | 2005 |   |
|                                                                                                      |   |   |   |   |   |   |   |
| CASH                FLOWS FROM OPERATING ACTIVITIES:                                                      |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |
| Net                Income (Loss)                                                                          |   |   |   |   | $ | (136,809 | ) | $ | 218,910 |   |
| Adjustments                to Reconcile Net Loss to Net Cash                                              |   |   |   |   |   |   |
| Provided                by Operations:                                                                    |   |   |   |   |   |   |
| Increase                (Decrease) in Notes Payable                                                       |   | 261,192 |   |   |   |   |
| Loss                (Gain) on sale of subsidiary                                                          |   | - |   |   | (376,705 | ) |
| Change                in Assets and Liabilities                                                           |   |   |   |   |   |   |
| Increase                (Decrease) in Accounts Payable/ Accrued Expenses                                  |   | (126,813 | ) |   | 142,561 |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |
| Net                Cash Provided(Used) by Operating Activities                                            |   | (2,430 | ) |   | (15,234 | ) |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |
| CASH                FLOWS FROM INVESTING ACTIVITIES:                                                      |   |   |   |   |   |   |
| Proceeds                from sale of subsidiary                                                           |   | - |   |   | 20,000 |   |
| Cash                Balance transferred in sale                                                           |   | - |   |   | (5,893 | ) |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |
| Net                Cash Provided (Used) by Investing Activities                                           |   |   |   |   | 14,107 |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |
| Net                Cash Provided (Used) by Discontinuing Operations                                       |   |   |   |   |  |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |
| NET                INCREASE (DECREASE) IN CASH AND EQUIVALENTS                                            |   | (2,430 | ) |   | (1,127 | ) |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |
| CASH                AND EQUIVALENTS AT BEGINNING OF PERIOD                                                |   | 2,530 |   |   | 14,077 |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |
| CASH                AND CASH EQUIVALENTS AT END OF PERIOD                                                 | $      | 100 |   | $ | 12,950 |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |
| The                accompanying notes are an integral part of theses financial                statements. |
|                                                                                                      |

| UniverCell                Holdings, Inc.(A                Development Stage Company) |
|--------------------------------------------------------------------------------------|
| Consolidated                Statements of Cash Flows                (Continued)      |

|                                                                                                     |   |  For                the six months ended June                30, |    |
|----------------------------------------------------------------------------------------------------------|--------|-----------------------------------------------------------------------|---------|
|                                                                                                     |   |  2006                                                            |    |  2005 |   |
| Cash                Paid For:                                                                            |   |                                                                  |    |   |   |
| Interest                                                                                                 |   |                                                                  |    |   |   |
| Taxes                                                                                                    |   | $                                                                     | -       |   | $ | - |   |
|                                                                                                     |   |                                                                  |    |   |   |   |   |
| Non-Cash                Activities:                                                                      |   |                                                                  |    |   |   |   |   |
| Shares                Issued for Services                                                                |   |                                                                  | -       |   |   | 57,716 |   |
| Note                issued in exchange for payables                                                      |   | $                                                                     | 261,192 |   |   |   |   |
|                                                                                                     |
| The                accompanying notes are an integral part of these financial                statements. |

----

----

| ·   | general              economic and business conditions; |
|--------------------|--------------------------------------------------------|

| ·   | our              ability to implement our business              strategy; |
|--------------------|---------------------------------------------------------------------------|

| ·   | our              access to financing; |
|--------------------|---------------------------------------|

| ·   | our              ability to successfully identify new business              opportunities; |
|--------------------|--------------------------------------------------------------------------------------------|

| ·   | our              ability to attract and retain key              executives; |
|--------------------|-----------------------------------------------------------------------------|

| ·   | the              effect of regulatory and legal              restrictions. |
|--------------------|----------------------------------------------------------------------------|

----

|   | 31.1 | Certification                of Principal Executive Officer - - Rule 13a-14(a)                Certification |
|--------|------|-------------------------------------------------------------------------------------------------------------|

|   | 31.2 | Certification                  of Principal Financial Officer - Rule 13a-14(a)                  Certification |
|--------|------|---------------------------------------------------------------------------------------------------------------|

|   | 32.1 | Certification                of Principal Executive Officer and Principal Financial Officer -                Sarbanes-Oxley Act Section 906 Certification |
|--------|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | UNIVERCELL                HOLDINGS, INC.  By:                /s/ SEAN Y. FULDASean                Y. FuldaChief                Executive Officer and PresidentChief                Financial Officer |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----